Microalgae—Sustainable Source for Alternative Proteins and Functional Ingredients Promoting Gut and Liver Health

Abstract Dietary proteins derived from animal sources, although containing well‐balanced profiles of essential amino acids, have considerable environmental and adverse health effects associated with the intake of some animal protein‐based products. Consuming foods based on animal proteins carries a...

Full description

Bibliographic Details
Published in:	Global Challenges
Main Authors:	Yahav Eilam, Hamdan Khattib, Noam Pintel, Dorit Avni
Format:	Article
Language:	English
Published:	Wiley 2023-05-01
Subjects:	alternative proteins bioactive compounds inflammatory bowel disease microalgae microbiome non‐alcoholic fatty liver disease
Online Access:	https://doi.org/10.1002/gch2.202200177

Similar Items

Oxidative Stress, Gut Bacteria, and Microalgae: A Holistic Approach to Manage Inflammatory Bowel Diseases
by: Shani Shoham, et al.
Published: (2025-06-01)

Microalgae as an Eco-Friendly and Functional Ingredient for Sustainable Aquafeed
by: Vimala Balasubramaniam, et al.
Published: (2025-08-01)

Chemically-Induced Production of Anti-Inflammatory Molecules in Microalgae
by: Zaida Montero-Lobato, et al.
Published: (2018-11-01)

The therapeutic potential of sphingolipids for cardiovascular diseases
by: Sapir Ya'ar Bar, et al.
Published: (2023-08-01)

Bioactive Ingredients from Microalgae: Food and Feed Applications
by: Diana PATRAS, et al.
Published: (2019-06-01)

The Prevalence of Metabolically associated Steatotic Liver Disease in Patients with Inflammatory Bowel Disease in Erbil City
by: Rieber Abdulrahman Kareem, et al.
Published: (2026-06-01)

The Ocean’s Pharmacy: Health Discoveries in Marine Algae
by: Mélanie Silva, et al.
Published: (2024-04-01)

The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy
by: Darren Fernandes, et al.
Published: (2022-08-01)

Exploring the role of gut microbiota in inflammatory bowel disease patients comorbid with non-alcoholic fatty liver disease
by: Jiachen Hu, et al.
Published: (2025-10-01)

Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity
by: Minjae Joo, et al.
Published: (2024-07-01)

Complementary and alternative medicine in children with inflammatory bowel disease
by: Elżbieta Krzesiek, et al.
Published: (2024-06-01)

Microalgae: Bioactive Composition, Health Benefits, Safety and Prospects as Potential High-Value Ingredients for the Functional Food Industry
by: Josephine Ampofo, et al.
Published: (2022-06-01)

Vitamin D, the gut microbiome and inflammatory bowel disease
by: Seyed-Amir Tabatabaeizadeh, et al.
Published: (2018-01-01)

Cystic fibrosis and inflammatory bowel disease: parallels in gut physiology and microbiota
by: Kaitlyn E. Barrack, et al.
Published: (2025-09-01)

Breaking barriers: bacterial-microalgae symbiotic systems as a probiotic delivery system
by: Hui Huang, et al.
Published: (2024-06-01)

Integrated annotation prioritizes metabolites with bioactivity in inflammatory bowel disease
by: Amrisha Bhosle, et al.
Published: (2024-03-01)

Microalgae: Cultivation Aspects and Bioactive Compounds
by: Diego de Freitas Coêlho, et al.

Young green quinoa as a sustainable functional crop with anti-inflammatory effects in macrophage cells
by: Hamdan Khattib, et al.
Published: (2025-06-01)

Microalgae and insects as alternative protein sources: Benefits and risks
by: G. I. Sutula, et al.
Published: (2024-01-01)

The role of gut microbiota associated metabolites in digestive disorders
by: Na Li, et al.
Published: (2024-06-01)

Vaccination and Complementary and Alternative Medicine in Patients with Inflammatory Bowel Disease
by: Sung Bae Kim, et al.
Published: (2014-04-01)

A fruitful approach to gut health and functionality
by: Paulo Sérgio Loubet Filho, et al.
Published: (2025-10-01)

Feasibility of microalgae as feedstock for alternative fuel in Malaysia: A review
by: Nazia Hossain, et al.
Published: (2020-11-01)

Editorial: Gut microbiota and gastrointestinal disorders
by: Abbas Yadegar, et al.
Published: (2022-11-01)

Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study
by: Ying-Hsiang Wang, et al.
Published: (2025-01-01)

Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities
by: Kanishk Aggarwal, et al.
Published: (2024-10-01)

Biomolecules from Microalgae and Cyanobacteria: Applications and Market Survey
by: Rihab Hachicha, et al.
Published: (2022-02-01)

The Interaction between Mushroom Polysaccharides and Gut Microbiota and Their Effect on Human Health: A Review
by: Jiahui Zhao, et al.
Published: (2023-01-01)

Effects of natural mono- and di-saccharide as alternative sweeteners on inflammatory bowel disease: a narrative review
by: Eunju Kim
Published: (2023-06-01)

Gut Microbiota and Gastrointestinal Symptoms in the Global Assessment of Obsessive–Compulsive Disorder: A Narrative Review of Current Evidence and Practical Implications
by: Giacomo Grassi, et al.
Published: (2024-05-01)

Intestinal Epithelial Axin1 Deficiency Protects Against Colitis via Altered Gut Microbiota
by: Shari Garrett, et al.
Published: (2024-04-01)

Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease
by: Femke M. Prins, et al.
Published: (2024-12-01)

Microalgae as functional feed for Atlantic salmon: effects on growth, health, immunity, muscle fatty acid and pigment deposition
by: Jonas Mueller, et al.
Published: (2023-10-01)

Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study
by: Eun Soo Kim, et al.
Published: (2022-04-01)

Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
by: Laila Aldars-García, et al.
Published: (2021-04-01)

Microalgae Bioactives for Functional Food Innovation and Health Promotion
by: José L. Guil-Guerrero, et al.
Published: (2025-06-01)

Evaluation of electroacupuncture acupoint selection’s potential in the treatment of inflammatory bowel disease: an investigation using a mouse gut microbiome and metabolomics model
by: Jiayin Lu, et al.
Published: (2026-06-01)

The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation
by: Chiara Amoroso, et al.
Published: (2020-05-01)

TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis
by: Si Hyoung Kim, et al.
Published: (2025-12-01)

Application of Nanomaterials in the Production of Biomolecules in Microalgae: A Review
by: Xiaolong Yuan, et al.
Published: (2023-11-01)